You are here

Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend

Board of Directors Authorizes New $11 Billion Share Repurchase Program

Thursday, October 23, 2014 - 4:05pm
EDT

 

The board of directors of Pfizer Inc. today declared a 26-cent fourth-quarter 2014 dividend on the company’s common stock, payable December 2, 2014, to shareholders of record at the close of business on November 7, 2014. The fourth-quarter 2014 cash dividend will be the 304th consecutive quarterly dividend paid by Pfizer.

The board of directors also authorized a new $11 billion share repurchase program to be utilized over time. This new program is in addition to the $1.3 billion of authorization remaining under the company’s current share repurchase program.

About Pfizer Inc.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.

Contact: 

Media:

Joan Campion, 212-733-2798

or

Investors:

Ryan Crowe, 212-733-8160